​

Funding Round

Series B - IgGenix

Series B - IgGenix

Investment Firm

Overview

IgGenix is a biotechnology company.

Announced Date

Feb 06, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Alexandria Venture Investments

Alexandria Venture Investments

Alexandria Venture Investments is a convertible_note and early_stage_venture and late_stage_venture and post_ipo and seed firm.

Participant Investors

4

Investor Name
Participant InvestorAlexandria Venture Investments
Participant InvestorEli Lilly
Participant InvestorSean Parker
Participant InvestorKhosla Ventures

Round Details and Background

IgGenix raised $40000000 on 2023-02-06 in Series B

IgGenix is a biotechnology company.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 04, 2020
Series A - IgGenix
2-10.0M
Jul 27, 2021
Series A - IgGenix
5-25.0M
Apr 18, 2022
Series A - IgGenix
1-undefined
Feb 06, 2023
Series B - IgGenix
5-40.0M

Recent Activity

There is no recent news or activity for this profile.